Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIND.L Regulatory News (IND)

  • There is currently no data for IND

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) IndigoVision Group

27 Mar 2020 09:34

RNS Number : 8588H
Nplus1 Singer Capital Markets Ltd
27 March 2020
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Nplus1 Singer Capital Markets Limited

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

 

INDIGOVISION GROUP PLC ORD

 

(c) Name of the party to the offer with which exempt principal trader is connected:

 

INDIGOVISION GROUP PLC ORD

 

 

(d) Date dealing undertaken:

26 March 2020

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

If YES, specify which:

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 1P

 

 

Purchase

 

625

 

375.51p

 

375.51p

 

ORD 1P

 

 

Sale

 

1,000

 

380p

 

380p

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

Date of disclosure:

27 March 2020

Contact name:

Sarah-Rose Perry, Jennifer Bentick, Nick Wright

Telephone number:

020 7496 3093

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FERGCGDXGXDDGGR
Date   Source Headline
16th Jun 20204:31 pmRNSCompletion of Acquisition by Bidco
16th Jun 20207:30 amRNSSuspension - IndigoVision Group Plc
15th Jun 20204:50 pmRNSForm 8.3 - IndigoVision Group plc
15th Jun 20201:20 pmRNSForm 8.5 (EPT/RI) IndigoVision group
15th Jun 202011:30 amRNSForm 8 (DD) - IndigoVision Group PLC
15th Jun 202011:28 amRNSForm 8 (DD) - IndigoVision Group PLC
12th Jun 20204:00 pmRNSDirector/PDMR Share Dealing
12th Jun 20202:35 pmRNSCourt Sanction of Scheme of Arrangement
9th Jun 20205:30 pmRNSIndigoVision Group
28th May 20204:18 pmRNSNotice of Court Hearing
27th May 20209:51 amRNSForm 8.5 (EPT/RI) IndigoVision Group
26th May 20202:20 pmRNSDirector's Dealing
26th May 202010:47 amRNSForm 8.5 (EPT/RI)
21st May 202012:52 pmRNSResult of resolutions passed at AGM
21st May 20207:00 amRNSAGM Trading Update
20th May 202010:10 amRNSForm 8.5 (EPT/RI) IndigoVision Group
19th May 20209:19 amRNSForm 8.5 (EPT/RI)
14th May 202010:58 amRNSForm 8.5 (EPT/RI) IndigoVision Group
12th May 20209:11 amRNSForm 8.3 - IndigoVision Group PLC
11th May 20203:00 pmRNSResults of Court Meeting and General Meeting
11th May 202011:40 amRNSForm 8.5 (EPT/RI) IndigoVision Group Plc
27th Apr 20202:30 pmRNS2019 Annual Report
27th Apr 202011:54 amRNSForm 8.5 (EPT/RI) Indigovision
27th Apr 202011:47 amRNSForm 8.3 - IndigoVision Group PLC
24th Apr 202011:18 amRNSForm 8.5 (EPT/RI)
24th Apr 20208:48 amRNSForm 8.3 - IndigoVision Group PLC
23rd Apr 202012:00 pmRNSForm 8.5 (EPT/RI)
22nd Apr 202011:36 amRNSForm 8.5 (EPT/RI)
17th Apr 202011:39 amRNSForm 8.5 (EPT/RI)
14th Apr 20205:35 pmRNSPosting of Scheme Document
14th Apr 20209:49 amRNSForm 8.5 (EPT/RI) IndigoVision Group
9th Apr 202010:10 amRNSForm 8.5 (EPT/RI) IndigoVision Group
8th Apr 20208:26 amRNSForm 8.3 - IndigoVision Group PLC
6th Apr 20205:52 pmRNSForm 8.3 - IndigoVision Group PLC
3rd Apr 20204:25 pmRNSHolding(s) in Company
3rd Apr 202011:51 amRNSForm 8.3 - IndigoVision Group PLC
3rd Apr 20209:56 amRNSForm 8.5 (EPT/RI) IndigoVision Group
3rd Apr 20208:53 amRNSForm 8.3 - IndigoVision Group PLC
2nd Apr 20203:50 pmPRNForm 8.3 Amendment IndigoVision Plc
2nd Apr 20203:48 pmPRNForm 8.3 Amendment IndigoVision Plc
2nd Apr 20203:29 pmPRNForm 8.3 - IndigoVision Plc
2nd Apr 20203:27 pmPRNForm 8.3 - IndigoVision Plc
2nd Apr 20202:50 pmPRNHolding(s) in Company
2nd Apr 202011:42 amRNSForm 8.5 (EPT/RI)
2nd Apr 202011:06 amRNSHolding(s) in Company
2nd Apr 20209:39 amRNSForm 8.3 - IndigoVision Group PLC
1st Apr 202011:10 amRNSForm 8.5 (EPT/RI) IndigoVision Group
1st Apr 20209:31 amRNSForm 8.3 - IndigoVision Group PLC
31st Mar 202010:27 amRNSForm 8.3 -IndigoVision Group PLC
31st Mar 20209:10 amRNSForm 8.3 - IndigoVision Group PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.